SOVREMENNAYA PEDIATRIYA.2016.1(73):75-81 

Innovations in the treatment and prevention of acute respiratory viral infections in children 

Kramarev, S. A. Vigovskaya O. V.

A.A. Bogomolets National Medical University, Kyiv, Ukraine 

Objective: To study the clinical features of acute respiratory viral infections (ARVI) in children; investigate the clinical efficacy of the antiviral plant preparation «Erebra» in children during the treatment and with the aim of ARVI prevention. 

Patients and methods. The study included 200 patients in the age from 1 month to 18 years with the presence of acute respiratory viral infections. Therapeutic activity of Erebra studied in 60 patients with a moderate form of ARVI in age from 3 to 18 years. Prophylactic activity was studied in 40 patients aged from 3 to 18 years who had a persistent form of Epstein-Barr virus infection and recurrent episodes of acute respiratory viral infections in the anamnesis. 

Results. Due to the treatment by Erebra was found a significant decrease in the duration of the main clinical manifestations of ARVI such as hyperthermia syndrome, rhinitis, tonsillitis, pharyngitis, and cough. The reduction of secondary bacterial complications on 26.7% in comparison with other groups is marked. Erebra, except medical, has antiviral activity, manifested in a decrease in the frequency of acute respiratory viral infections in 1.6 times in children taking it with the aim of prophylactic. 

Conclusions. The «Erebra» is an effective and safe means of treatment and prevention of acute respiratory viral infections in children.

Key words: acute respiratory viral infections, children, Erebra. 

REFERENCES

1. Afanaseva IA. 2005. Giporamin v lechenii ORVI u detey. RMZh. 13; 21: 1404—1405.

2. Berezhniy VV. 2013. PedIatrIya. NatsIonalniy pIdruchnik. U 2 t. Za red prof VV Berezhnogo. T2. Kiyiv

: 1024.

3. Bortnikova VV. 2011. Eksperimentalnoe izuchenie bezopasnosti giporamina — novogo fitopreparata protivovirusnogo deystviya. Biomeditsina

. 3: 106—108.

4. Maliy VP, Polukchi OK, Andreychin MA ta In. 2010. Grip (sezonniy I pandemIchniy). MetodichnI rekomendatsIYi. HarkIv: 54.

5. Ershova IB. 2014. Effektivnost giporamina (Erebra) v lechenii i profilaktike virusnyih zabolevaniy u detey. Zdorove rebenka. 8: 110—113.

6. Gerasimov SV, Belova GA, Pavuk GL et al. 2014. New approaches to the treatment of an acute respiratory viral infections among children. Sovremennaya pediatriya. 4(60): 111—114.

7. Kryuchko TA, Kushnereva TV, Ostapenko VP, Kolenko IA. 2014. Problematic issues of outpatient management of children with acute respiratory viral infections. Sovremennaya pediatriya. 8(64): 65-68.

8. Mavlyanov SM, Ismailov AI, Islambekov ShYu i dr. 2001. Rastitelnyie dubilnyie veschestva. Himiya prirod soedineniy. 1: 293—307.

9. Lezhenko GO, Abaturov OE, Pashkova OE, Pantyushenko LI. 2013. Rol α- defenzinIv 1–3 u formuvannI antimIkrobnogo zahistu v dItey, hvorih na retsidivuyuchiy bronhIt, viklikaniy bakterIyami rodu Haemophilus. Zdorove rebenka. 2(45).

10. Krepkova LV, Shkarenkov AA, Anikanova VV i dr. 1998. Toksikologicheskoe izuchenie giporamina. Tez dokl Rossiyskogo natsionalnogo kongressa «Chelovek i lekarstvo». Moskva, 21—25 apr. 1998 g. M: 580.

11. Chukaev SA, Rodnaeva OA. 2009. Otsenka spektra antioksidantnoy aktivnosti giporamina in vitro. Byulleten VSNTs SO RAMN. 2: 140—142.

12. Shipulina LD, Leneva IA, Fedyakina IT. 1998. Izuchenie vliyaniya giporamina na aktivnost virusnoy neyraminazyi. Tezisyi dokl VI Ros nats kongr «Chelovek i lekarstvo». Moskva, 21—25 aprelya 1998 g. M: 76.

13. Shipulina LD. 2000. Issledovanie antivirusnoy aktivnosti i drugih biologicheskih svoystv giporamina — novogo protivovirusnogo preparata. Trudyi VILAR. Himiya, tehnologiya, meditsina. M: 228—239.

14. Shipulina LD, Leneva IA, Fedyakina IT. 2000. K voprosu o mehanizme deystviya giporamina. Trudyi VILAR. Himiya, tehnologiya, meditsina. Moskva: 250—257.

15. Shipulina LD, Leneva IA, Fedyakina IT. 2000. Eksperementalnoe izuchenie aktivnosti giporamina metodom immunofermentnogo analiza v otnoshenii respiratorno-sintsitialnogo virusa. Trudyi VILAR. Himiya, tehnologiya, meditsina. Moskva: 258—262.

16. Shuldyakova OG. 2007. Respiratornyie infektsii u detey. Lekarstvennyie sredstva, primenyaemyie pri virusnyih zabolevaniyah. Pod red MG Romantsova, FI Ershova. Moskva: 233—277.

17. Shipulina LD, Vichkanova SA, Fateeva TV, Krutikova NM. 1996. Eksperimentalno-klinicheskoe izuchenie protivovirusnogo preparata giporamina. Traditsionnaya meditsina: teoreticheskie i prakticheskie aspektyi. Materialyi Vtorogo nauch kongr. Cheboksaryi. Ch1: 107.

18. Vichkanova SA, Krutikova NM, Vartanyan RV i dr. 2000. Effektivnost giporamina pri virusnyih infektsiyah u detey. Tezisyi dokl VII Ros nats kongr. «Chelovek i lekarstvo». Moskva, 10—14 apr. 2000 g. Moskva: 208.

19. Arimboor R, Arumughan C. 2012. Effect of polymerization on antioxidant and xanthine oxidase inhibitory potential of sea buckthorn (H. rhamnoides) proanthocyanidins. J Food Sci. 77(10): 1036—41. http: //wwv.ncbi.nlm.nih.gov/pubmed/ 22938149.

20. Chauhan AS, Negi PS, Ramteke RS. 2007. Antioxidant and antibacterial activities of aqueous extract of Seabuckthorn (Hippophae rhamnoides) seeds. Fitoterapia. 78(7-B): 590—2. http://www.ncbi.nlm.nih.gov/pubmed/17651916. http://dx.doi.org/10.1016/j.fitote.2007.06.004; PMid:17651916

21. Holt PG et al. 2004. Nat Immunol. 5: 695—698. http://dx.doi.org/10.1038/ni0704-695; PMid:15224096

22. Jayashankar B, Mishra KP, Ganju L. 2014. Supercritical extract of Seabuckthorn Leaves (SCE200ET) inhibited endotoxemia by reducing inflammatory cytokines and nitric oxide synthase 2 expression. Int lmmunopharmacol. 20(1): 89—94. http://www.ncbi.nlm.nih.gov/ pubmedl2459–4274.

23. Maheshwari DT, Yogendra Kumar MS. 2011. Antioxidant and heoatoorotective activities of phenolic rich fraction of Seabuckthorn (Hippophae rhamnoides L.) leaves. Food Chem Toxicol. 49(9): 2422—8. http://www.ncbi.nlm.nih.gov/ pubmed /21723907. http://dx.doi.org/10.1016/j.fct.2011.06.061; PMid:21723907

24. Suryakumar G, Gupta A. 2011. Medicinal and therapeutic potential of Sea buckthorn (Hippophae rhamnoides L.). J Ethnopharmacol. 18; 138(2): 268—78. http://www.ncbi.nlm.nih. gov/pubmed/ 21 963–559.

25. Upadhyay NK, Kumar MS, Gupta A. 2010. Antioxidant, cytoprotective and antibacterial effects of Sea buckthorn (Hippophae rhamnoides L.) leaves. Food Chem Toxicol. 48(12): 3443—8. http://www.ncbi.nlm.nih.gov/pubmed/20854873. http://dx.doi.org/10.1016/j.fct.2010.09.019; PMid:20854873

26. Upadhyay NK, Shipulina LD. Antioxidant, cytoprotective and antibacterial effects of Sea buckthorn (Hippophae rhamnoides L.) leaves. Anti-viral, antiJmicrobial and toxicological studies on Seabuckthorn (Hippophaerhamnoides). LD Shipulina, ON Tolkachev, LV Krepkova et al. Multipurpose Wonder Plant. Ed by V Singh. 9.

27. Yogendra Kumar MS, Tirpude RJ, Maheshwari DT. 2013. Anlioxidant and antimicrobial propefties of phenolic rich fraction of Seabuckthorn (Hippophae rhamnoides L.) leaves in vitro. Food Chem. 141(4): 3443—50. http://www.ncbi.nlm.nih.gov/pubmed/23993505. http://dx.doi.org/10.1016/j.foodchem.2013.06.057; PMid:23993505